Conneqt Health Limited

As of June 30, 2024, Conneqt Health Limited carries a market capitalization of 20.59M, placing it among publicly traded companies globally. Its enterprise value stands at 19.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Conneqt Health Limited's next confirmed earnings release is scheduled for February 26, 2027.

As of June 30, 2024, Conneqt Health Limited has 300.86M shares outstanding.

These figures are as of June 30, 2024. The price-to-sales ratio is 1.29, and the price-to-book ratio stands at 5.04.

These figures are as of June 30, 2024. The EV/Sales ratio of 1.75 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 19.10M versus a market cap of 20.59M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2024, Conneqt Health Limited maintains a current ratio of 1.28, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 94.50, indicating elevated leverage, while an interest coverage ratio of -5.90 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2024. Return on assets (ROA) is negative at -49.77, reflecting losses generated across the asset base. Inventory turnover of 0.38 indicates how many times Conneqt Health Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 21, 2026, Conneqt Health Limited's stock has declined approximately 66.67% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.03.

Over the twelve months ended June 30, 2024, Conneqt Health Limited generated 10.91M in revenue and converted that into -6.77M in net income, yielding earnings per share of -0.03. EBITDA reached -6.98M, while operating income came in at -7.21M.

As of June 30, 2024, Conneqt Health Limited holds 5.35M in cash and equivalents against 3.86M in total debt, resulting in a net debt position of 2.75M. Total book value stands at 4.09M, with working capital of 2.30M providing operational flexibility.

These figures cover the twelve months ended June 30, 2024.

Over the twelve months ended June 30, 2024, Conneqt Health Limited posted a gross margin of 92.68, reflecting its pricing power and cost economics. The operating margin of -66.08 and net profit margin of -62.04 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -36.87, meaning Conneqt Health Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Conneqt Health Limited's most recent stock split took place on June 3, 2025 with a 44:45 split ratio.

As of June 30, 2024, Conneqt Health Limited has an Altman Z-Score of -9.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.